|
⚲
|
| Keyboard |
| Hawkhill Therapeutics Ltd | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002140690 |
| Sale | 2026-04-07 (0.2 M Offered, 0.2 M Sold) |
| Fund | |
| Phone | 5555555555 |
| Address | Life Sciences Innovation Hub Dundee Scotland, X0 DD1 5JJ |
| Source | [EDGAR] |
| Amount Raised ($k) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-06-23 (D) |
| Exemption | 506(b) |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Timothy Sparey | Executive Officer | |
| Francisca Peixoto | Executive Officer | |
| Mary Canning | Executive Officer | |
| Antoine Boulanger | Executive Officer | |
| Christopher Woodland | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Qube Research & Technologies Ltd
✚
|
X0 | |
|
BMO Capital Markets Ltd
✚
|
X0 | |
|
Barclays Bank PLC
✚
|
X0 | |
|
Baillie Gifford & Co
✚
|
X0 | |
|
BP Investment Management Ltd
✚
|
X0 | |
|
Baillie Gifford & Co Ltd
✚
|
X0 | |
|
Aubrey Capital Management Ltd
✚
|
X0 | |
|
Asset Value Investors Ltd
✚
|
X0 | |
|
Attestor Ltd
✚
|
X0 | |
|
Arini Captial Management Ltd
✚
|
X0 |